Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HRMY Harmony Biosciences Holdings, Inc.

Pre-Mkt 04-27 06:48:52 EDT

30.80

-1.28

-3.99%

盘前30.71

-0.09-0.29%

05:57 EDT

High32.13	Low30.77	Vol933.30K
Open31.80	D1 Closing32.08	Amplitude4.22%
Mkt Cap1.77B	Tradable Cap1.37B	Total Shares57.60M
T/O29.06M	T/O Rate2.09%	Tradable Shares44.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":30.8,"timestamp":1777060800000,"preClose":32.08,"halted":0,"volume":933299,"hourTrading":{"tag":"盘前","latestPrice":30.71,"preClose":30.8,"latestTime":"05:57 EDT","volume":2014,"amount":60813.555739999996,"timestamp":1777283836259,"change":-0.09,"changeRate":-0.002922,"amplitude":0.032143},"delay":0,"changeRate":-0.03990024937655853,"floatShares":44560063,"shares":57596358,"eps":2.71,"marketStatus":"Pre-Mkt","change":-1.28,"latestTime":"04-27 06:48:52 EDT","open":31.8,"high":32.125,"low":30.77,"amount":29059332.992355,"amplitude":0.042238,"askPrice":34.48,"askSize":5,"bidPrice":29.75,"bidSize":1,"shortable":3,"etf":0,"ttmEps":2.71,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777296600000},"marketStatusCode":1,"adr":0,"listingDate":1597809600000,"exchange":"NASDAQ","adjPreClose":30.8,"preHourTrading":{"tag":"盘前","latestPrice":30.71,"preClose":30.8,"latestTime":"05:57 EDT","volume":2014,"amount":60813.555739999996,"timestamp":1777283836259,"change":-0.09,"changeRate":-0.002922,"amplitude":0.032143},"postHourTrading":{"tag":"盘后","latestPrice":30.8,"preClose":30.8,"latestTime":"18:36 EDT","volume":55272,"amount":1702234.55,"timestamp":1777070173215,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5741596241000332,"impliedVol":0.317,"impliedVolPercentile":0.06},"requestUrl":"/m/hq/s/HRMY/wiki","defaultTab":"wiki","newsList":[{"id":"2629839456","title":"Harmony Biosciences to report first-quarter results, host conference call and webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2629839456","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629839456?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:11","pubTimestamp":1776946274,"startTime":"0","endTime":"0","summary":"Harmony Biosciences scheduled release of first-quarter fiscal 2026 financial results for May 7, 2026, before US market open.Conference call, webcast set for May 7, 2026, at 8:30 a.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL2SpGvC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629040051","title":"Harmony Biosciences (HRMY) Is Up 9.7% After New CFO Hire And Reiterated 2026 Guidance – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629040051","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629040051?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:07","pubTimestamp":1776866860,"startTime":"0","endTime":"0","summary":"On April 14, 2026, Harmony Biosciences Holdings, Inc. appointed veteran biopharmaceutical executive Glenn Reicin as Chief Financial Officer and Executive Team member, while reiterating its 2026 net product revenue guidance of US$1.00 billion to US$1.04 billion.\nThis combination of a new finance leader with deep capital markets experience and maintained revenue expectations points to an emphasis on execution, capital discipline, and continuity in the company’s growth plans.\nWe’ll now examine...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-is-up-97-after-new-cfo-hire-and-rei","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-is-up-97-after-new-cfo-hire-and-rei","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629424150","title":"Harmony Biosciences : Oppenheimer Raises Target Price to $72 From $62","url":"https://stock-news.laohu8.com/highlight/detail?id=2629424150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629424150?lang=en_us&edition=fundamental","pubTime":"2026-04-22 21:46","pubTimestamp":1776865596,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN41510O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627290286","title":"Harmony Biosciences to present Phase 3 ARGUS extension data for EPX-100 in Dravet syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2627290286","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627290286?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:07","pubTimestamp":1776341231,"startTime":"0","endTime":"0","summary":"Harmony Biosciences scheduled an encore presentation of open-label extension data from its Phase 3 ARGUS trial of EPX-100  in Dravet syndrome at American Academy of Neurology 2026.Results were already presented previously, with the next presentation set for April 22, 2026.Update is expected to focus on preliminary longer-term experience from ongoing treatment, including how participants are doing over time.Trial remains in enrollment, keeping EPX-100 in active late-stage development for Dravet syndrome.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL2WmwyR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627452164","title":"Harmony Biosciences reiterates 2026 net product revenue guidance of $1-1.04 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2627452164","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627452164?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:10","pubTimestamp":1776168618,"startTime":"0","endTime":"0","summary":"Harmony Biosciences reiterated 2026 net product revenue guidance of USD 1.0 billion to USD 1.04 billion.Outlook reflects expectations for WAKIX net sales to exceed USD 1 billion in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief on April 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL1N9Dwr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445213","title":"Harmony Biosciences appoints Glenn Reicin as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445213","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627445213?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:09","pubTimestamp":1776168562,"startTime":"0","endTime":"0","summary":"Harmony Biosciences appointed Glenn Reicin as chief financial officer, effective immediately.Reicin most recently served as CFO at Eccogene, leading buildout of financial infrastructure to prepare for an IPO.He previously served as CFO and chief operating officer at Alladapt Immunotherapeutics, overseeing fundraising and operational buildout.Harmony reiterated 2026 net product revenue guidance of $1.0 billion to $1.04 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via Business Wire  on April 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL6LH5tF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627544598","title":"Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627544598","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627544598?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:05","pubTimestamp":1776168300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUA69XMN1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445977","title":"Harmony Biosciences - Reiterates 2026 Net Product Revenue Guidance of $1.0-$1.04 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627445977?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:05","pubTimestamp":1776168300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUA69XMN1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627414729","title":"Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627414729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627414729?lang=en_us&edition=fundamental","pubTime":"2026-04-14 17:40","pubTimestamp":1776159616,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ICU Medical (ICUI) and Harmony Biosciences Holding...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-icu-medical-icui-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-icu-medical-icui-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0240878834.USD","XLV","LU0128526141.USD","LU0240877869.USD","ICUI","BK4007","BK4082","BK4137","ICU","HCSG","LU0205194284.USD","SG9999015978.USD","SG9999015945.SGD","HRMY","SG9999015986.USD","BK4198","SG9999015952.SGD","BK4588","LU0012050646.USD","XBI","LU0106261612.USD","BK4581","LU0205193047.USD","LABU","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625860926","title":"Harmony Biosciences director Troy Ignelzi files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2625860926","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625860926?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:08","pubTimestamp":1775506109,"startTime":"0","endTime":"0","summary":"Harmony Biosciences disclosed Troy A. Ignelzi as a director in an initial Form 3 filing dated April 2, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDL8lNGHp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624657330","title":"Harmony Biosciences announces annual shareholder meeting via webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2624657330","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624657330?lang=en_us&edition=fundamental","pubTime":"2026-04-03 20:02","pubTimestamp":1775217730,"startTime":"0","endTime":"0","summary":"Harmony Biosciences set annual stockholder meeting for May 14, 2026, to be held virtually.Ballot includes election of four Class III directors to serve through 2029, including nominees Geno Germano, Troy Ignelzi, Ron Philip, Andreas Wicki.Shareholders also will vote on ratification of Deloitte & Touche as independent auditor for fiscal year 2026.Advisory vote scheduled on compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL3mHknd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509329","title":"Harmony Biosciences appoints Anastasiou as Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509329","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624509329?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:16","pubTimestamp":1775132215,"startTime":"0","endTime":"0","summary":"Harmony Biosciences (HRMY) announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Directors, includin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-appoints-anastasiou-as-chief-operating-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-appoints-anastasiou-as-chief-operating-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624064645","title":"Harmony Biosciences names Peter Anastasiou COO in executive reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2624064645","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624064645?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:07","pubTimestamp":1775131628,"startTime":"0","endTime":"0","summary":"Harmony Biosciences appointed Peter Anastasiou as chief operating officer.Anastasiou previously served on Harmony board, most recently was CEO of Capsida Biotherapeutics.Harmony named Troy Ignelzi to board to fill vacancy created by Anastasiou resignation; Ignelzi is CFO of Rapport Therapeutics.Ignelzi previously served as CFO of Karuna Therapeutics, where he led capital raises including IPO.Board nominated Geno J. Germano for election at 2026 annual meeting; Germano most recently was CEO of Elucida Oncology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via Business Wire  on April 02, 2026, and is solely responsible for the information c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL5mNs8c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","HRMY","IE0002141913.USD","BMY","BK4532","LU1883839398.USD","LU1074936037.SGD","LU0096364046.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1989771016.USD","LU0306806265.USD","IE00BJJMRZ35.SGD","LU1670710588.SGD","LU1670711040.USD","LU2125154935.USD","LU1868837300.USD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU0456855351.SGD","BK4585","LU0985481810.HKD","LU2125154778.USD","LU0225284248.USD","LU1868836757.USD","LU1868836914.USD","LU1868836591.USD","LU0225771236.USD","BK4007","BK4559","LU0237698245.USD","RAPP","LU0321505868.SGD","LU1093756325.SGD","LU1093756168.USD","LU1585245621.USD","LU1670710661.SGD","LU1430594728.SGD","BK4534","LU0321505439.SGD","LU0061475181.USD","LU1261432733.SGD","BK4581","LU2360032135.SGD","IE0009355771.USD","LU0882574055.USD","LU0114720955.EUR","LU1291159041.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624050691","title":"Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2624050691","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624050691?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:05","pubTimestamp":1775131500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUACCV5X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624555431","title":"Harmony Biosciences to present at Needham Virtual Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2624555431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624555431?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:43","pubTimestamp":1774993380,"startTime":"0","endTime":"0","summary":"Harmony Biosciences management to participate in fireside chat at 25th Annual Needham Virtual Healthcare Conference on April 13, 2026 at 9:30 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via Business Wire  on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL8TVB6f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617266598","title":"Harmony Biosciences Eyes Blockbuster Future After Record Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2617266598","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617266598?lang=en_us&edition=fundamental","pubTime":"2026-03-05 08:19","pubTimestamp":1772669975,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, Inc. (($HRMY)) has held its Q4 earnings call. Read on for the main highlights of the call. Harmony Biosciences’ lates...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/harmony-biosciences-eyes-blockbuster-future-after-record-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/harmony-biosciences-eyes-blockbuster-future-after-record-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614118570","title":"Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2614118570","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614118570?lang=en_us&edition=fundamental","pubTime":"2026-02-26 16:32","pubTimestamp":1772094724,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings recently reported Q4 2025 results showing net income of US$22.49 million and diluted EPS of US$0.38, alongside full-year 2025 net income of US$158.69 million and reiterated 2026 WAKIX net revenue guidance of US$1.00 billion to US$1.04 billion.\nAt the same time, FDA approval extending WAKIX to treat cataplexy in pediatric narcolepsy patients and progress securing its intellectual property framework could be important for Harmony’s long-term WAKIX franchise and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-is-down-201-after-reaffirming-wakix","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-is-down-201-after-reaffirming-wakix","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614508717","title":"Oppenheimer Reaffirms Their Buy Rating on Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614508717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614508717?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:16","pubTimestamp":1772025407,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Argyrides from Oppenheimer reiterated a Buy rating on Harmony Biosciences Holdings, with a price target of $62....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614821740","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), CareDx (CDNA) and Sotera Health (SHC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614821740","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614821740?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:50","pubTimestamp":1772023845,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Harmony Biosciences Holdings (HRMY – Research Report), CareDx (CD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-caredx-cdna-and-sotera-health-shc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-caredx-cdna-and-sotera-health-shc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4581","XBI","BK4137","LABU","BK4139","BK4585","HCSG","BK4121","HRMY","LU0029874061.USD","BK4023","BK4116","CDNA","CD","BK4588","XLV","LU0128526141.USD","SHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614081337","title":"Harmony Biosciences Holdings, Inc.  : Deutsche Bank Cuts Target Price to $30 From $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2614081337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614081337?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:07","pubTimestamp":1772021220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nAQN2LNOA1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harmonybiosciences.com","stockEarnings":[{"period":"1week","weight":0.027},{"period":"1month","weight":0.1163},{"period":"3month","weight":-0.1635},{"period":"6month","weight":0.0182},{"period":"1year","weight":0.0466},{"period":"ytd","weight":-0.1769}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.035612},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.051691},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.016911},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.048657},{"month":5,"riseRate":0.6,"avgChangeRate":0.050645},{"month":6,"riseRate":0.6,"avgChangeRate":-0.007672},{"month":7,"riseRate":0.8,"avgChangeRate":0.041515},{"month":8,"riseRate":0.8,"avgChangeRate":0.05943},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023406},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.006378},{"month":11,"riseRate":0.833333,"avgChangeRate":0.105341},{"month":12,"riseRate":0.5,"avgChangeRate":0.02881}],"exchange":"NASDAQ","name":"Harmony Biosciences Holdings, Inc.","nameEN":"Harmony Biosciences Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Harmony Biosciences Holdings, Inc.,HRMY,Harmony Biosciences Holdings, Inc.股票,Harmony Biosciences Holdings, Inc.股票老虎,Harmony Biosciences Holdings, Inc.股票老虎国际,Harmony Biosciences Holdings, Inc.行情,Harmony Biosciences Holdings, Inc.股票行情,Harmony Biosciences Holdings, Inc.股价,Harmony Biosciences Holdings, Inc.股市,Harmony Biosciences Holdings, Inc.股票价格,Harmony Biosciences Holdings, Inc.股票交易,Harmony Biosciences Holdings, Inc.股票购买,Harmony Biosciences Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}